NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tropic Biosciences

Tropic Biosciences

Private
NorwichHealthcare & Life Scienceshttps://tropic.bio/

Last Round

Series C

Extension

Mar 12, 2026

Est. Valuation

$875M

Total Funding Raised

$179.9M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Tropic Biosciences is an agricultural biotechnology company that develops high-performing commercial varieties of tropical crops like bananas, coffee, and rice using gene-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Supply Chain

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

gene editingCRISPRagtechRNAiagricultural biotechnologyGEiGScrop geneticsbioinformaticsfood securitygene-edited cropsGMO alternativestrait developmentseed technologysustainable agricultureagri-genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tropic Biosciences Comps

Public and private peers based on sector, stage, and business model.

Tropic Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tropic Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionMar 12, 2026
Series CJul 6, 2022
Series BJun 3, 2020
Series AJun 13, 2018

Key People

Founding team and executive leadership

Gilad Gershon

Co-Founder, CEO

Founding Team

Eyal Maori

Chief Technology Officer

Executive Team

Mark Williams

Chief Financial Officer

Executive Team

Tropic Biosciences Investors

Notable investors and investment history

Tropic Biosciences investors
InvestorRounds
Agronomics LimitedSeries B
Just ClimateSeries C Extension
DisruptADSeries C
TemasekSeries C Extension, Series B
Bits x BitesSeries B, Series A
Future Planet Capital RegionalSeries B
ForbionSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    $105M round completed.

  • Mar 12, 2026

    Siddarth Shrikanth joins the Board of Directors.

Tropic Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tropic Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tropic Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorwich
Employee Range158
Year Founded2016
Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.